{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:30:14Z","timestamp":1784287814589,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.yebeh.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T13:18:32Z","timestamp":1561468712000},"page":"138-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Increased frequency of psychosis after second-generation antiepileptic drug administration in adults with focal epilepsy"],"prefix":"10.1016","volume":"97","author":[{"given":"Naoto","family":"Adachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Akanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryouhei","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutoshi","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Sekimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiichi","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2019.06.002_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2005.09.024","article-title":"Adverse psychiatric effects of antiepileptic drugs","volume":"68","author":"Gilliam","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2009.0238","article-title":"Antiepileptic drugs and psychopathology of epilepsy: an update","volume":"11","author":"Mula","year":"2009","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0015","series-title":"The neuropsychiatry of epilepsy","first-page":"133","article-title":"The effects of antiepileptic drugs on behavior","author":"Schmitz","year":"2011"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0020","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.1975.03240220043019","article-title":"Delayed idiosyncratic psychosis with diphenylhydantoin","volume":"231","author":"McDanal","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.296.6628.1071","article-title":"Psychiatric symptoms associated with carbamazepine","volume":"296","author":"Mathew","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1528-1157.1965.tb03359.x","article-title":"Psychotic episodes in Zarondan treatment","volume":"6","author":"Fischer","year":"1965","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2019.06.002_bb0035","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1528-1157.1959.tb04284.x","article-title":"Experiences with alpha-ethyl-alpha-methylsuccimide in the treatment of epilepsy","volume":"60","author":"Lorentz de Haas","year":"1959","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yebeh.2017.08.039","article-title":"Psychiatric and behavioural side effects of antiepileptic drugs in adults with epilepsy","volume":"76","author":"Chen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yebeh.2017.04.003","article-title":"Psychiatric side effects and antiepileptic drugs: observations from prospective audits","volume":"71","author":"Stephen","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0050","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2006.08.008","article-title":"Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy","volume":"10","author":"Weintraub","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/JCP.0b013e318253a186","article-title":"Behavioral adverse effects of antiepileptic drugs in epilepsy","volume":"32","author":"Eddy","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.172.3.235","article-title":"Epilepsy and non-organic non-affective psychosis","volume":"172","author":"Bredkjaer","year":"1998","journal-title":"Brit J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0065","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1111\/j.1528-1167.2007.01230.x","article-title":"Interictal psychosis in comparison with schizophrenia. A prospective study","volume":"48","author":"Tadokoro","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0070","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0075","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.bp.108.056721","article-title":"Epileptic, organic, and genetic vulnerabilities for timing of the development of onset of interictal psychosis","volume":"196","author":"Adachi","year":"2010","journal-title":"Brit J Psychiatry"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0080","series-title":"Neuropsychiatric symptoms of epilepsy","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-319-22159-5_5","article-title":"Delusions and hallucinations","author":"Adachi","year":"2016"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0085","series-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0090","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1528-1157.2002.22402.x","article-title":"Psychoses and epilepsy: are interictal and postictal psychoses distinct clinical entities?","volume":"43","author":"Adachi","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1528-1157.1998.tb01431.x","article-title":"Predictive value of interictal epileptiform discharges during non-REM sleep on scalp EEG recordings for lateralization of epileptogenesis","volume":"39","author":"Adachi","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/j.1528-1167.2007.01058.x","article-title":"Duration of postictal psychotic episodes","volume":"48","author":"Adachi","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0110","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yebeh.2017.10.012","article-title":"Seizure frequency at the time of first-episode interictal psychosis","volume":"79","author":"Adachi","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1535-7511.2010.01382.x","article-title":"An update on antiepileptic drugs and suicide: are there definitive answers yet?","volume":"10","author":"Hesdorffer","year":"2010","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1996.tb00161.x","article-title":"Psychotic and severe behavioural reactions with vigabatrin: a review","volume":"93","author":"Ferrie","year":"1966","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0135","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1212\/WNL.53.7.1503","article-title":"Psychiatric adverse events during vigabatrin therapy","volume":"53","author":"Levinson","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0896-6974(96)00083-7","article-title":"Zonisamide and psychosis","volume":"10","author":"Matsuura","year":"1997","journal-title":"J Epilepsy"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0145","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1528-1157.2002.16000.x","article-title":"Occurrence of psychosis inpatients with epilepsy randomized to tiagabine or placebo treatment","volume":"43","author":"Sackellares","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yebeh.2007.03.015","article-title":"Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature","volume":"11","author":"Brandt","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0155","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10072-011-0869-9","article-title":"Vulnerability of an epileptic psychosis; sodium valproate with lamotrigine, forced normalization, postictal psychosis, or all","volume":"33","author":"Turan","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0160","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1059-1311(98)80037-X","article-title":"An audit of topiramate use in general neurology clinic","volume":"7","author":"Crawford","year":"1998","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0165","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1528-1157.2003.05402.x","article-title":"Topiramate and psychiatric adverse events in patients with epilepsy","volume":"44","author":"Mula","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0170","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1684\/j.1950-6945.2003.tb00573.x","article-title":"Acute psychosis associated with levetiracetam","volume":"5","author":"Youroukos","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/0091217415589295","article-title":"Psychotic and depressive symptoms after gabapentine treatment","volume":"49","author":"Evrensel","year":"2015","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.yebeh.2012.01.012","article-title":"Impact of antiepileptic drugs on genesis of psychosis","volume":"23","author":"Noguchi","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0190","first-page":"133","article-title":"Psychiatric symptoms related to the use of lamotrigine: a review of the literature","volume":"23","author":"Villari","year":"2008","journal-title":"Funct Neurol"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0195","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/brain\/aww196","article-title":"Psychotic disorders induced by antiepileptic drugs in people with epilepsy","volume":"139","author":"Chen","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1528-1157.2001.09000.x","article-title":"Reexamination of interictal psychoses based on DSM4 psychosis classification and international epilepsy classification","volume":"42","author":"Kanemoto","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2019.06.002_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/jnnp.67.2.231","article-title":"Epileptic psychoses and anticonvulsant drug treatment","volume":"67","author":"Matsuura","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019302471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505019302471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:26:43Z","timestamp":1761503203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505019302471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":41,"alternative-id":["S1525505019302471"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.002","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased frequency of psychosis after second-generation antiepileptic drug administration in adults with focal epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}